Axogen, Inc. — Director's Dealing 2018

Aug 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-08-07

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-07	Common Stock	F	10060	$39.30	Disposed	407970	Direct

Footnotes

F1: This Form is being filed to report the delivery of shares of Common Stock of the Company for payment of tax liabilities that resulted from the exercise of a stock option reported on Form 4 for the reporting person filed on August 6, 2018. The fair market value of the Company's Common Stock on the date of exercise of such stock option was $39.25, and the amount of shares transferred to the Company on August 7, 2018 was based on the tax liability that accrued on the date of the exercise on August 2, 2018.